✦ LIBER ✦

Lung cancer classification: The relationship of disease extent and cell type to survival in a clinical trials population

✍ Scribed by Clifton F. Mountain; John M. Lukeman; Samuel P. Hammar; Dean W. Chamberlain; Walter F. Coulson; David L. Page; Thomas A. Victor; Louis H. Weiland; LUNG CANCER STUDY GROUP PATHOLOGY COMMITTEE

Publisher: John Wiley and Sons
Year: 1987
Tongue: English
Weight: 764 KB
Volume: 35
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.2930350302

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Abdominal computed tomography in small c

Abdominal computed tomography in small cell lung cancer: Assessment of extent of disease and response to therapy

✍ Daniel C. Ihde; N. Reed Dunnick; Anita Johnston-Early; Paul A. Bunn; Martin H. C 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 570 KB

Expert review of the diagnosis and histo

Expert review of the diagnosis and histologic classification of Hodgkin disease in a population-based cancer registry : Interobserver reliability and impact on incidence and survival rates

✍ Sally L. Glaser; Ronald F. Dorfman; Christina A. Clarke 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 3 views

Reply to a Comparison of Survival and Di

Reply to a Comparison of Survival and Disease-Specific Survival in Surgically Resected, Lymph Node-Positive Bronchioloalveolar Carcinoma Versus Nonsmall Cell Lung Cancer: Implications for Adjuvant Therapy

✍ John M. Varlotto; John C. Flickinger; Abram Recht; Margaret C. Nikolov; Malcolm 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 1 views

Author reply to recent improvement in th

Author reply to recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy

✍ Katsuyuki Hotta; Yoshiro Fujiwara; Keitaro Matsuo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB

A randomized trial to compare intravenou

A randomized trial to compare intravenous and oral etoposide in combination with cisplatin for the treatment of small cell lung cancer

✍ David H. Johnson; John C. Ruckdeschel; James H. Keller; Gary H. Lyman; Gerald J. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

Prognostic factors for survival of stage

Prognostic factors for survival of stage I nonsmall cell lung cancer patients : A population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003

✍ S.-H. Ignatius Ou; Jason A. Zell; Argyrios Ziogas; Hoda Anton-Culver 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 2 views

## Abstract ## BACKGROUND. Platinum‐based adjuvant chemotherapy in randomized trials has failed to provide a survival benefit in patients with resected stage I nonsmall cell lung cancer (NSCLC). Using data from the California Cancer Registry (CCR), we explored factors that had detrimental effects